HCA Healthcare, Inc. (NYSE:HCA) Holdings Lifted by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 209.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 18,587 shares of the company’s stock after purchasing an additional 12,571 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in HCA Healthcare were worth $5,579,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Integrated Advisors Network LLC grew its position in HCA Healthcare by 0.6% in the 3rd quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after buying an additional 31 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after acquiring an additional 36 shares in the last quarter. Mediolanum International Funds Ltd boosted its stake in HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after purchasing an additional 36 shares in the last quarter. Hartford Funds Management Co LLC boosted its stake in HCA Healthcare by 1.6% during the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after purchasing an additional 39 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its stake in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after buying an additional 40 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on HCA. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Royal Bank of Canada reduced their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 1.7 %

Shares of HCA Healthcare stock opened at $316.07 on Monday. The firm has a market cap of $78.49 billion, a price-to-earnings ratio of 14.39, a P/E/G ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock has a 50-day simple moving average of $313.53 and a 200-day simple moving average of $350.82.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm earned $5.90 earnings per share. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.